Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matzku

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|January 15, 1988
Antibody targeting to the murine lymphoma ESb-MP: increased accumulation due to reduced internalization into lymphoma cells as compared to normal lymphoid cellsS Matzku, H Kirchgessner, V Schirrmacher
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Iodination of monoclonal IgG antibodies at a sub-stoichiometric level: immunoreactivity changes related to the site of iodine incorporationS Matzku, H Kirchgessner, M Nissen
The Journal of Investigative Dermatology|December 1, 1990
Autoradiographic evaluation of monoclonal antibodies' access to melanoma-associated antigens in melanoma xenograftsS Matzku, J Schmid, W Tilgen
Cancer Biochemistry Biophysics|December 1, 1983
DNase I inhibitions in tumors of different metastasizing capacities: a possible index of invasivenessB Mély-Goubert, S Matzku, D Bellgrau
Arzneimittel-Forschung|November 1, 1988
Optimisation of the covalent binding of monoclonal antibodies to liposomesH P Weckenmann, S Matzku, H Stricker
Zeitschrift Fur Gastroenterologie. Verhandlungsband|January 1, 1976
[State of isolation of CEA-like substances from human neoplastic gastric mucosa]W Rapp, S Matzku, K H Wurster
Cancer Immunology, Immunotherapy : CII|May 1, 1993
Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphyC Somasundaram, S Matzku, J Schuhmacher, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1996
Development of a bispecific F(ab')2 conjugate against the complement receptor CR3 of macrophages and a variant CD44 antigen of rat pancreatic adenocarcinoma for redirecting macrophage-mediated tumor cytotoxicityC Somasundaram, R Arch, S Matzku, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Quantitation of antibody uptake in spontaneous metastasesU Schmid, V Schirrmacher, H Bihl, et al.
Cancer Research|March 1, 1989
Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodiesS Matzku, A Wenzel, S Liu, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|January 15, 1988
Antibody targeting to the murine lymphoma ESb-MP: increased accumulation due to reduced internalization into lymphoma cells as compared to normal lymphoid cellsS Matzku, H Kirchgessner, V Schirrmacher
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Iodination of monoclonal IgG antibodies at a sub-stoichiometric level: immunoreactivity changes related to the site of iodine incorporationS Matzku, H Kirchgessner, M Nissen
The Journal of Investigative Dermatology|December 1, 1990
Autoradiographic evaluation of monoclonal antibodies' access to melanoma-associated antigens in melanoma xenograftsS Matzku, J Schmid, W Tilgen
Cancer Biochemistry Biophysics|December 1, 1983
DNase I inhibitions in tumors of different metastasizing capacities: a possible index of invasivenessB Mély-Goubert, S Matzku, D Bellgrau
Arzneimittel-Forschung|November 1, 1988
Optimisation of the covalent binding of monoclonal antibodies to liposomesH P Weckenmann, S Matzku, H Stricker
Zeitschrift Fur Gastroenterologie. Verhandlungsband|January 1, 1976
[State of isolation of CEA-like substances from human neoplastic gastric mucosa]W Rapp, S Matzku, K H Wurster
Cancer Immunology, Immunotherapy : CII|May 1, 1993
Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphyC Somasundaram, S Matzku, J Schuhmacher, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1996
Development of a bispecific F(ab')2 conjugate against the complement receptor CR3 of macrophages and a variant CD44 antigen of rat pancreatic adenocarcinoma for redirecting macrophage-mediated tumor cytotoxicityC Somasundaram, R Arch, S Matzku, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Quantitation of antibody uptake in spontaneous metastasesU Schmid, V Schirrmacher, H Bihl, et al.
Cancer Research|March 1, 1989
Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodiesS Matzku, A Wenzel, S Liu, et al.
Pageof 10